Efficacy and safety of oral mifepristone on preinduction cervical ripening at term pregnancy prospective randomized control study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20233293Keywords:
Bishop score, Favourable cervix, MifepristoneAbstract
Background: Cervical ripening is important prerequisite for induction of labour, induction is indicated when it is advantageous to mother and fetus. Successful induction of labour decreases caesarean rate. Beyond term pregnancy there will be placental insufficiency, it leads to complications such as oligohydramnios thereby cord compression, birth asphyxia, increased incidence of operative delivery. Induction at term pregnancy has the potential to improve the neonatal outcomes. Aim was to study the efficacy and safety of oral mifepristone on cervical ripening prior to induction of labor at term pregnancy and to compare the feto maternal outcome with control group.
Methods: Total 112 pregnant women at term pregnancy, where pregnancy can be continued for another 48 hours with bishop score 4 or less were selected. Sample was equally divided into study group (56 women) to receive 200mg mifepristone and control Group group (56 women) to receive placebo orally. Bishop score was assessed at 24hours and 48hours. In women who did not enter labor spontaneously other modes of induction was done.
Results: There is significant improvement in bishop score at 24 hr and 48hr in study group p value 0.001, 80.35% women in study group and 50 % women in control group delivered vaginally. 33.9% women of study group and 10.7% women of control group delivered spontaneously. Requirement of PGE2 gel and oxytocin was significantly lesser in study group, there was no significant adverse effect seen on mother and newborn compared to control group.
Conclusions: Cervical ripening with mifepristone prior to induction of labour at term improves bishop score and decreases rate of failed induction and cesarean section rate, with good neonatal outcome.
References
Drife JO. The history of labour induction: How did we get here?. Best Pract Res Clin Obstet Gynaecol. 2021;77:3-14.
Arulkumaran S. Caesarean section rates are increasing worldwide. Preface. Best Pract Res Clin Obstet Gynaecol. 2013;27(2):151-2.
Vrouenraets FP, Roumen FJ, Dehing CJ, Van den Akker ES, Aarts MJ, et al. Bishop score and risk of cesarean delivery after induction of labor in nulliparous women. Obstet Gynecol. 2005;105(4):690-7.
Chatterjee MS, Ramchandran K, Ferlita J, Mitrik ML. Prostaglandin E2 (PGE2) vaginal gel for cervical ripening. Euro J Obstet Gynecol Reprod Biol. 1991;38(3):197-202.
Papanikolaou EG, Plachouras N, Drougia A, Andronikou S, Vlachou C, Stefos T, Paraskevaidis E, et al. Comparison of misoprostol and dinoprostone for elective induction of labour in nulliparous women at full term: a randomized prospective study. Reprod Biol Endocrinol. 2004;2(1):1-7.
Väisänen-Tommiska M, Butzow R, Ylikorkala O, Mikkola TS. Mifepristone-induced nitric oxide release and expression of nitric oxide synthases in the human cervix during early pregnancy. Human Reprod. 2006;21(8):2180-4.
Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol. 1992;80(6):972-5.
Giacalone PL, Targosz V, Laffargue F, Boog G, Faure JM. Cervical ripening with mifepristone before labor induction: a randomized study. Obstet Gynecol. 1998;92(4):487-92.
Stenlund P, Ekman G, Aedo AR, Bygdeman M. Induction of labor with mifepristone,-A randomized, double-blind study versus placebo. Acta obstet Gynecol Scand. 1999;78(9):793-8.
Wing DA, Fassett MJ, Mishell Jr DR. Mifepristone for preinduction cervical ripening beyond 41 weeks’ gestation: a randomized controlled trial. Obstet Gynecol. 2000;96(4):543-8.
Chourasia UH, Jain MK, Fidvi JI. The role of oral mifepristone in pre-induction cervical ripening at term. Int J Reprod Contracept Obstet Gynecol. 2019;8(11):4337-4340.
McGill J. Shetty A. Mifepristone and misoprostol in the induction of labor at term. Int J Gynaecol Obstet. 2007;96(2):80-4.
Giacalone PL, Targosz V, Laffargue F, Boog G, Faure JM. Cervical ripening with mifepristone before labor induction: a randomized study. Obstet Gynecol. 1998;92(4):487-92.
Hapangama D, Neilson JP. Mifepristone for induction of labour. Cochrane Database of Systematic Reviews. 2009(3).
Yelikar K, Deshpande S, Deshpande R, Lone D. Safety and efficacy of oral mifepristone in pre-induction cervical ripening and induction of labour in prolonged pregnancy. J Obstet Gynecol India. 2015;65(4):221-5.
Athawale R, Acharya N, Samal S, Hariharan C. Effect of mifepristone in cervical ripening for induction of labour. Int J Reprod Contracept Obstet Gynecol. 2013;2(1):35-8.
Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol. 1992;80(6):972-5.
Baev OR, Rumyantseva VP, Tysyachnyu OV, Kozlova OA, Sukhikh GT. Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial. Euro J Obstet Gynecol Reprod Biol. 2017;217:144-9.
